GYL Financial Synergies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $741K | Sell |
|
|||||
|
2024
Q2 | $793K | Sell |
|
|||||
|
2024
Q1 | $1.23M | Sell |
|
|||||
|
2023
Q4 | $1.36M | Sell |
|
|||||
|
2023
Q3 | $1.66M | Sell |
|
|||||
|
2023
Q2 | $3.37M | Buy |
|
|||||
|
2023
Q1 | $797K | Buy |
|
|||||
|
2022
Q4 | $632K | Buy |
|
|||||
|
2022
Q3 | $538K | Buy |
|
|||||
|
2022
Q2 | $582K | Buy |
|
|||||
|
2022
Q1 | $420K | Sell |
|
|||||
|
2021
Q4 | $374K | Buy |
|
|||||
|
2021
Q3 | $288K | Buy |
|
|||||
|
2021
Q2 | $201K | Sell |
|
|||||
|
2021
Q1 | $220K | Buy |
|
|||||
|
2020
Q4 | $216K | Sell |
|
|||||
|
2020
Q3 | $252K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $232K | Buy |
|